About

As life sciences and health tech organizations deepen their investments in real-world data from claims, the electronic health record, and linked registries, the supporting infrastructure processing that data can have a profound effect on outcomes. Standard coding systems weren’t designed for today’s use cases, and without the right tools, data gaps can delay trials, reduce precision, and create compliance risk.

In this virtual event, industry leaders will discuss how smarter terminology and data infrastructure can accelerate clinical trial cohort creation, reduce friction, and unlock higher returns on data investments.

Moderator

Jesse McQuarters, Branded Content Editor at STAT

Speakers

Amol Bhalla, MD, M.SCI, MHSA, MBA, Chief Clinical Informaticist, IMO Health

Amol Bhalla, the Chief Clinical Informaticist at IMO Health, is known for developing solutions, strategies, and novel methodologies in clinical informatics. He leads the incorporation of novel clinical informatics principles across the company, oversees the clinical team, and participates in executive decision-making and strategic planning. Previously, Amol was the Director of Clinical Informatics and Data Science at an RWD/RWE precision medicine oncology organization. He empowered teams to develop novel approaches to derive insights from multidimensionally disparate data. His research has focused on statistical machine learning approaches, modeling of the clinical and genomic domain, and developing semantically-driven clinical architectures.

Ediz Calay, Senior Solutions Manager, IMO Health

Ediz is the commercial strategy owner of IMO Health’s life sciences and health tech solutions, with responsibility in identifying solution fit and scaling offerings to market. Prior to joining IMO Health, he has worked with multiple top 20 pharma companies across RWE projects, clinical trial optimization and therapeutic development across oncology, immunology, infectious, metabolic, and rare disease areas. He holds a PhD in physiology and biochemistry and completed his post-doctoral training in biophysics studying the pathophysiology of obesity and diabetes.

Mika Newton, CEO, xCures

Mika Newton is the CEO of xCures, a health technology company that has developed an AI-enabled medical records structuring and information extraction platform. Mika is an expert in healthcare data management, with a focus on data completeness and universality. He has a proven track record of bringing transformative technologies to market, driving growth, and fostering innovation.